We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

FDA Approval for Genentech’s Subcutaneous Rituximab

News   Mar 31, 2017 | Original Story from Genentech

 
FDA Approval for Genentech’s Subcutaneous Rituximab
 
 
Advertisement
 

RELATED ARTICLES

Prevalence of Coronavirus Antibodies Declining in England

News

Tests on more than 365,000 people in England have shown that the antibody response to the virus that causes COVID-19 wanes over time.

READ MORE

Mapping the Immune Landscape in Pancreatic Cancer To Guide Immunotherapy

News

A new study led by the University of Michigan Rogel Cancer Center combined single-cell RNA sequencing with two other investigative techniques to create a network of interactions that suppress the body's immune response in and around pancreatic tumors.

READ MORE

Adaptate Biotherapeutics Appoints Stewart Kay as Chief Business Officer

News

Adaptate Biotherapeutics (Adaptate) today announced the appointment of Stewart Kay as Chief Business Officer (CBO).

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Biopharma

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE